A detailed history of Humankind Investments LLC transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Humankind Investments LLC holds 3,330 shares of LH stock, worth $681,251. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,330
Previous 3,156 5.51%
Holding current value
$681,251
Previous $717,000 1.39%
% of portfolio
0.2%
Previous 0.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$209.01 - $232.56 $36,367 - $40,465
174 Added 5.51%
3,330 $727,000
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $1,383 - $1,591
7 Added 0.22%
3,156 $717,000
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $101,329 - $111,736
-504 Reduced 13.8%
3,149 $633,000
Q2 2023

Aug 09, 2023

SELL
$211.93 - $241.33 $213,837 - $243,501
-1,009 Reduced 21.64%
3,653 $881,000
Q1 2023

Apr 25, 2023

SELL
$213.32 - $257.83 $119,459 - $144,384
-560 Reduced 10.72%
4,662 $1.07 Million
Q4 2022

Jan 26, 2023

BUY
$203.72 - $248.97 $91,877 - $112,285
451 Added 9.45%
5,222 $0
Q3 2022

Nov 09, 2022

BUY
$204.81 - $262.19 $155,655 - $199,264
760 Added 18.95%
4,771 $977,000
Q2 2022

Aug 05, 2022

BUY
$213.86 - $277.87 $30,154 - $39,179
141 Added 3.64%
4,011 $940,000
Q1 2022

May 09, 2022

BUY
$259.82 - $298.18 $100,030 - $114,799
385 Added 11.05%
3,870 $1.02 Million
Q4 2021

Mar 21, 2022

BUY
$271.6 - $314.21 $158,614 - $183,498
584 Added 20.13%
3,485 $1.1 Million
Q3 2021

Mar 21, 2022

BUY
$274.82 - $308.34 $36,276 - $40,700
132 Added 4.77%
2,901 $816,000
Q2 2021

Mar 21, 2022

BUY
$251.87 - $278.14 $181,850 - $200,817
722 Added 35.27%
2,769 $764,000
Q1 2021

Mar 21, 2022

BUY
$204.88 - $255.03 $419,389 - $522,046
2,047 New
2,047 $522,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.3B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Humankind Investments LLC Portfolio

Follow Humankind Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.